Soleno Therapeutics Inc share price logo

Soleno Therapeutics Inc Share Price

NASDAQ: SLNO

Mid Cap

$52.62

-0.02

(-0.03%)

as on

Soleno Therapeutics Inc Stock Performance

as on April 15, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $52.61
    $52.69
    downward going graph

    0.02%

    Downside

    0.13%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $29.43
    $90.32
    downward going graph

    44.07%

    Downside

    71.65%

    Upside

    downward going graph

Soleno Therapeutics Inc share price movements today

Previous Close
$52.64
Open
$52.61
Volume
4.3M
Day's Low - High
$52.61 - $52.69
52 Week Low - High
$29.43 - $90.32

Soleno Therapeutics Inc Historical Returns

1 Month Return
+ 55.95 %
3 Month Return
+ 23.98 %
1 Year Return
-24.8 %
3 Year Return
+ 1529.72 %
5 Year Return
+ 187.65 %

Soleno Therapeutics Inc Stock Fundamentals & Key Indicators

Check Soleno Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.7B

EPS (TTM)

3.9483

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

134.95

Industry PE ratio

0.49917808219178084

PEG Ratio

0

EBITDA

17.0M

Revenue (TTM)

190.4M

Profit Margin

10.97%

Return On Equity TTM

6.01%

Soleno Therapeutics Inc Stock Valuation

Track how Soleno Therapeutics Inc P/E has moved over time to understand its valuation trends.

Soleno Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-40.29x)

September 30, 2025

Industry (0.50x)

April 14, 2026

Today (134.95x)

April 14, 2026

Highest (-0.37x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: 134.95x

Soleno Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Soleno Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.7B187.65%134.9510.97%
BUY$42.7B140.76%138.848.45%
BUY$111.0B102.67%28.532.94%
NA$35.6BNA124.865.37%
BUY$79.2B55.14%18.0531.41%

Stock Returns calculator for Soleno Therapeutics Inc Stock including INR - Dollar returns

The Soleno Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Soleno Therapeutics Inc investment value today

Current value as on today

₹81,316

Returns

-₹18,684

(-18.68%)

Returns from Soleno Therapeutics Inc Stock

-₹24,829 (-24.83%)

Dollar Impact

₹6,144 (+6.14%)

Analyst Recommendation on Soleno Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Soleno Therapeutics Inc. Average target price of $60.12

Soleno Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Soleno Therapeutics Inc.

What analysts predicted

12.48%UPSIDE

Target Price

$60.12

Current Price

$52.62

Analyzed by

12 Analysts

Target

$60.12

Soleno Therapeutics Inc target price $60.12, a slight upside of 12.48% compared to current price of $52.62. According to 12 analysts rating.

Soleno Therapeutics Inc Stock’s Investor Sentiment and Interest

Investment in Soleno Therapeutics Inc Shares on INDmoney has grown by 540.00% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:540.00% versus previous 30 day period

Search interest for Soleno Therapeutics Inc Stock has increased by 354% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:354% versus previous 30 day period

Soleno Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
3
-
-
-
-
-
32
66
91
Gross Profit
0
2
0
0
-
-
-
31
64
90
Operating Income
-10
-13
-23
-23
-80
-59
-45
-6
22
40
EBITDA
-8
-12
-20
-22
-78
-49
-41
-2
27
45
Interest Expense
-
0
-
-
-
0
1
1
1
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-11
-21
-21
-76
-55
-43
-4
26
43
Income Tax Expense
-2
2
1
-
-
-
-
-
-
-
Net Income
-10
-11
-21
-21
-76
-55
-43
-4
26
43
Net Profit Margin
0.00%
-327.80%
0.00%
0.00%
0.00%
0.00%
0.00%
-14.42%
39.40%
47.27%

Soleno Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
-1,553
-
-
-
-
-
-
-
190
Gross Profit
0
-1,554
-1
-2
-2
-2
-2
-1
-1
187
Operating Income
-13
-12
-14
-23
-31
-31
-24
-41
-187
14
EBITDA
-6
-8
-9
-28
-22
-30
-22
-37
-173
28
Interest Expense
-
-
0
-
-
0
0
-
0
5
Depreciation
-
1
1
1
1
1
1
1
1
2
Income Before Tax
-12
-13
-11
-30
-24
-30
-24
-38
-175
20
Income Tax Expense
0
-1
2
5
-9
-1
-3
2
-175
-
Net Income
-12
-15
-13
-30
-24
-30
-24
-38
-175
20
Net Profit Margin
-831.63%
1.01%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
10.97%

Soleno Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-11
-21
-21
-76
-55
-43
-4
26
43
Operating Cash Flow
-6
-12
-17
-14
-23
-32
-12
43
48
Investing Cash Flow
-
-115
-120
4
6
22
-7
-91
-125
Financing Cash Flow
123
0
152
2
57
3
15
217
-99
Change in Cash
117
-126
14
-8
39
-6
-4
170
-176

Soleno Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-12
-11
-30
-24
-30
-24
-38
-175
20
Operating Cash Flow
-9
-11
-17
-25
-27
-20
-24
-69
46
Investing Cash Flow
0
0
0
0
0
0
-
-225
-201
Financing Cash Flow
23
17
14
53
0
14
180
213
137
Change in Cash
14
5
-2
28
-27
-6
155
-81
-17

Global Institutional Holdings in Soleno Therapeutics Inc

Funds
Holdings
Vanguard Group Inc
5.92%
Citadel Advisors Llc
2.83%
COMMODORE CAPITAL LP
2.32%
BRAIDWELL LP
2.3%
COMMODORE CAPITAL LP
2.62%

Soleno Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 06 April

    Mon, 09:51 PM

    -

    Neurocrine Biosciences announces acquisition of Soleno for $53 per share, valuing the deal at approximately $2.9 billion.

    Tue, 03:10 AM

    -

    Soleno Therapeutics closes at $52.26, up 32.31%, following acquisition news; trading volume surged 2,148% above average.

Insights on Soleno Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, SLNO stock has moved up by 1529.7%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SLNO has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 38.7% return, outperforming this stock by 63.5%

About Soleno Therapeutics Inc

Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
OrganisationSoleno Therapeutics Inc
Headquarters100 Marine Parkway, Redwood City, CA, United States, 94065
IndustryBiotechnology
CEODr. Anish Bhatnagar M.D.
E-voting on sharesClick here to vote

Key Management of Soleno Therapeutics Inc

Name

Title

Ms. Kristen Yen M.S.

Senior Vice President of Global Clinical Operations and Patient Advocacy

Dr. Anish Bhatnagar M.D.

Chairman, President & CEO

Ms. Patricia C. Hirano M.P.H.

Senior Vice President of Regulatory Affairs

Mr. James H. MacKaness

Executive Officer

Ms. Meredith Manning M.B.A.

Chief Commercial Officer

Mr. Jesse Schumaker

General Counsel

Ms. Jennifer Fulk

Chief Financial Officer

Ms. Lauren Budesheim

Senior Vice President of People

Dr. Neil M. Cowen M.B.A., Ph.D.

Senior Vice President of New Product Planning

Dr. Michael Huang M.D.

Senior Vice President of Clinical Development

FAQs

What is Soleno Therapeutics Inc share price today?

Soleno Therapeutics Inc share price today is $52.62 as on at the close of the market. Soleno Therapeutics Inc share today touched a day high of $52.69 and a low of $52.61.

What is the 52 week high and 52 week low for Soleno Therapeutics Inc share?

Soleno Therapeutics Inc share touched a 52 week high of $90.32 on and a 52 week low of $29.43 on . Soleno Therapeutics Inc stock price today i.e. is closed at $52.62,which is 41.74% down from its 52 week high and 78.80% up from its 52 week low.

What is Soleno Therapeutics Inc's market capitalisation today?

Soleno Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Soleno Therapeutics Inc Stock (SLNO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Soleno Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Soleno Therapeutics Inc Shares that will get you 0.0285 shares as per Soleno Therapeutics Inc share price of $52.62 per share as on April 15, 2026 at 1:29 am IST.

What is the minimum amount required to buy Soleno Therapeutics Inc Stock (SLNO) from India?

Indian investors can start investing in Soleno Therapeutics Inc (SLNO) shares with as little as ₹93.082 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.82 in Soleno Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Soleno Therapeutics Inc share’s latest price of $52.62 as on April 15, 2026 at 1:29 am IST, you will get 0.1900 shares of Soleno Therapeutics Inc. Learn more about fractional shares .

What are the returns that Soleno Therapeutics Inc has given to Indian investors in the last 5 years?

Soleno Therapeutics Inc stock has given 187.65% share price returns and 24.21% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?